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SYNOPSIS
The institutional and community norms that lead to the stigmatization of 
tuberculosis (TB) are thought to hinder TB control. We performed a systematic 
review of the literature on TB stigma to identify the causes and evaluate the 
impact of stigma on TB diagnosis and treatment. Several themes emerged: fear 
of infection is the most common cause of TB stigma; TB stigma has serious 
socioeconomic consequences, particularly for women; qualitative approaches 
to measuring TB stigma are more commonly utilized than quantitative surveys; 
TB stigma is perceived to increase TB diagnostic delay and treatment noncom-
pliance, although attempts to quantify its impact have produced mixed results; 
and interventions exist that may reduce TB stigma. 
Future research should continue to characterize TB stigma in different popu-
lations; use validated survey instruments to quantify the impact of TB stigma 
on TB diagnostic delay, treatment compliance, and morbidity and mortality; 
and develop additional TB stigma-reduction strategies. 
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The social determinants of health refer to the institu-
tional, community, and interpersonal factors that affect 
health outside of the ease with which an individual can 
access medical services.1 Stigma, which is shaped and 
promulgated by institutional and community norms 
and interpersonal attitudes, is a social determinant of 
health.2 Stigma is a process that begins when a par-
ticular trait or characteristic of an individual or group 
is identified as being undesirable or disvalued.3 The 
stigmatized individual often internalizes this sense of 
disvalue and adopts a set of self-regarding attitudes 
about the marked characteristic including shame, 
disgust, and guilt.4 These attitudes produce a set of 
behaviors that include hiding the stigmatized trait, with-
drawing from interpersonal relationships, or increasing 
risky behavior.5,6 Stigmatization is conceptually distinct 
from discrimination—another social determinant of 
health—in that the primary goal of discrimination is 
exclusion, not necessarily for the target to feel ashamed 
or guilty.7,8 Stigmatized individuals can, however, suf-
fer discrimination and status loss at the hands of the 
broader community, whose norms have caused them 
to be perceived as undesirable.3,9
Stigmatization is a complex process involving insti-
tutions, communities, and inter- and intrapersonal 
attitudes. While it has been recognized as an important 
social determinant of health and health disparities, 
the difficulties in identifying, characterizing, measur-
ing, and tracking changes in stigmatization over time 
have made it challenging to justify devoting resource-
intensive interventions to the problem.2,10 One excep-
tion is human immunodeficiency virus (HIV)/acquired 
immunodeficiency syndrome (AIDS) research, where 
the interactions among stigma, HIV risk behaviors, 
and HIV-associated outcomes have been fairly well 
characterized.11,12 Substantially less study has been 
conducted on the mechanisms through which stigma 
impacts the health of individuals at risk for or infected 
with tuberculosis (TB).
In this article, we review the available literature 
on TB stigma. Our goal was to identify the causes of 
TB stigma and to assess the impact of stigma on TB 
diagnosis and treatment. We identified three themes 
in the existing literature on TB stigma: (1) studies that 
characterize and measure TB stigma, (2) studies that 
explore the effect of TB stigma on TB diagnosis and 
treatment, and (3) studies that describe interventions 
to reduce TB stigma and the impact of these interven-
tions on TB diagnosis and treatment. We also consid-
ered the gaps in existing research on stigma and the 
TB pandemic, and assessed potential interventions to 
reduce the health impact of TB stigma. 
METHODS
Search strategy 
Using the terms “tuberculosis AND stigma,” “tuberculo-
sis AND stigmatization,” “tuberculosis AND stigmatized,” 
“tuberculosis AND stigmatizing,” “TB AND stigma,” “TB 
AND stigmatization,” “TB AND stigmatized,” and “TB 
AND stigmatizing,” we searched PubMed for articles 
addressing TB stigma. We reviewed the reference sec-
tions of identified articles to locate additional publica-
tions not found in our initial search.
We reviewed each article, noting its date of publica-
tion, geographic location, study type, use of qualitative 
and/or quantitative methods, and key results and con-
clusions. We then assigned it to one of three mutually 
exclusive content categories, based on the authors’ 
primary focus. The first category involved articles 
characterizing and measuring TB stigma, including 
articles identifying the causes and socioeconomic con-
sequences of TB stigma. This category also included 
articles reporting on the development or evaluation of 
TB assessment tools and articles using qualitative or 
quantitative techniques to measure TB stigma in vari-
ous populations. The second category included articles 
focusing on the theoretical and empirical connections 
between TB stigma and TB diagnosis and treatment. 
The third category included articles on interventions 
to reduce TB stigma and the impact of such reductions 
on TB diagnostic delay and treatment compliance. We 
excluded articles that did not fit into these categories 
or were not in English. 
RESULTS
The literature review yielded 168 articles (Figure 1), 
159 from the PubMed search and nine from the 
reference sections of identified articles. Of the 168 
articles, 69 were excluded from this review. The most 
common reasons for exclusion included focus on the 
effects of HIV stigma on TB diagnosis and treatment 
(five articles), one or more of the authors was affili-
ated with TB-related institutions although the article 
was not on TB (13 articles), and the article was not in 
English (six articles). Of the 99 articles included, the 
majority (52 articles) characterized or measured TB 
stigma. A smaller number (38 articles) examined the 
impact of TB stigma on TB diagnosis and treatment. 
Relatively few (nine articles) described interventions 
to reduce TB stigma. Included studies were published 
between 1976 and 2009. Geographically, most studies 
involved Asia/Pacific Islands (33%) or Africa/Middle 
East (28%) compared with multiregional (17%), North 
America (9%), Latin/South America (8%), or Europe/
Russia (4%).
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Characterizing and measuring TB stigma
Characterizing TB stigma. Understanding the origins of 
TB stigma is integral to reducing its impact on health. 
Using surveys, focus groups, and unstructured and 
focused interviews, a number of studies have explored 
the causes of TB stigma. Although there is geographic 
and cultural variation in the explanations for why TB 
is stigmatized, most authors identify the perceived 
contagiousness of TB as a leading cause of stigmatiza-
tion.13–22 Lack of knowledge regarding routes of TB 
transmission may also contribute to TB stigma.23–26 
Even among people with relatively good knowledge 
of TB transmission and transmissibility, however, the 
perceived risk of transmission can lead to stigmatiza-
tion and isolation of individuals with TB.27 
In areas of high HIV prevalence, where HIV and 
TB co-infection is common, the link between the 
two diseases has contributed to the stigmatization of 
TB.28–34 TB is perceived as a marker for HIV positiv-
ity; therefore, HIV-associated stigma is transferred to 
TB-infected individuals.35 Other causes of TB stigma 
include the perceived associations of TB with malnutri-
tion,36 poverty,37 being foreign-born,38 and low social 
class.14 As with HIV, TB is stigmatized in this context 
because it is linked to other disvalued characteristics, 
which themselves are also social determinants of health. 
Finally, TB stigma may occur because an affected indi-
vidual’s community believes he or she must have done 
something to deserve to be infected.19,27 This judgment 
may reflect the belief that TB is divine punishment 
for a moral or personal failing, which then licenses 
stigmatization.14 
TB-infected individuals perceive themselves to 
be at risk for a number of stigma-related social and 
economic consequences. Because the most common 
result of TB stigma is isolation from other members of 
the community, TB infection can substantially impact 
economic opportunities. For example, the stigmatiza-
tion of TB in Ghana has led to the prohibition of 
TB-infected individuals from selling goods in public 
markets and attending community events.17 When an 
individual dies of TB, fear of TB stigma can lead fami-
lies to hide the cause of death from other members of 
the community, even when such information might be 
useful in targeted TB screening.39 Similarly, fear of TB 
stigma can lead infected individuals to hide their TB 
status from their families.16,22 TB stigma also results in 
a sense of shame or guilt, leading to self-isolation as 
TB-infected individuals internalize their community’s 
negative judgments about the disease.37,40
The socioeconomic consequences of TB stigma 
differ in men and women. In general, men are more 
concerned with the impact of TB stigma on their eco-
nomic prospects, which include job loss and reduced 
income.41–43 While TB stigma also affects their financial 
Figure 1. Flow diagram of literature search on TB and stigmatization (n=168)
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status, women tend to be more concerned that TB 
stigma will adversely impact their marriage prospects 
or that their families will shun them.43–46 In some areas, 
however, men are more worried than women about 
the effect of TB stigma on their marriage opportuni-
ties.46 Married women with children may fear that 
their husbands will reject them if they are diagnosed 
with TB and that they will be unable to care for their 
families.43,47 
Measuring TB stigma. In addition to characterizing the 
causes of TB stigma, several authors have attempted to 
capture the prevalence of perceived, internalized, and 
actually experienced TB stigma and to compare the 
extent of TB stigma in different geographic regions. 
Many studies use qualitative instruments (e.g., in-depth 
interviews and focus groups) to gauge the degree to 
which TB is seen as stigmatized in a community. Con-
siderable geographic variability exists in the perceived 
prevalence of TB stigma, with 27% to 80% of at-risk 
individuals reporting that TB is stigmatized in their 
communities.48–50 TB stigma is felt more strongly in 
certain subpopulations, including women, refugees, 
individuals from rural areas, and people with lower 
education levels.51–54 Discordance between perceived 
and actual experiences of stigmatization among at-risk 
and TB-infected individuals has also been documented. 
For example, in one study of at-risk, TB-negative 
Mexican Americans, half the participants believed that 
someone with TB would experience social isolation. In 
a demographically similar comparison population of 
individuals with documented TB infection, none had 
actually experienced social isolation.38
To assist in better understanding the prevalence of 
TB stigma, several authors have developed standard-
ized TB stigma assessment tools. For example, Macq 
et al. introduced and validated a quantitative TB stigma 
questionnaire based on surveys designed to measure 
mental health stigma.55 Their instrument captures both 
perceived and internalized TB stigma. Van Rie et al. 
developed a comprehensive TB stigma assessment scale 
covering domains such as fear of disease transmission, 
attitudes toward TB, association of TB with shame and 
judgment, and disclosure of disease status. Their scale 
has good internal consistency and reasonable test-retest 
reliability.56 Although measuring any type of stigma is a 
challenge, a number of instruments have been devel-
oped to quantify the stigmatization of other conditions; 
these may also be adapted to measure perceived and 
internalized TB stigma.57
The effects of TB stigma on  
TB diagnosis and treatment
It is a widely held view that TB stigma contributes to 
delays in TB diagnosis and negatively impacts treatment 
compliance. A number of qualitative studies report 
that community members without TB, individuals with 
TB, and health-care providers who treat TB perceive 
TB stigma to be a barrier to prompt diagnosis of the 
disease.58–62 At-risk individuals report that fear of TB 
stigma and the social and economic impact of stigma 
affects their willingness to undergo TB screening and 
to seek medical care after the onset of symptoms asso-
ciated with TB.63–65 Individuals with TB-like symptoms 
may first attempt to see private physicians so as to avoid 
TB stigma. Because private clinics typically have longer 
waits for appointments, this may translate to diagnostic 
delay and increased financial costs for patients.66 
Several studies suggest that health-care providers 
and at-risk community members perceive TB stigma to 
have a more substantial impact on women’s health-care-
seeking behavior than on men’s.67–70 Balasubramanian 
et al., however, found that although women in south 
India felt TB stigma more strongly than men, they were 
more likely to access health services.71 Only one study 
recommended considering the impact of TB stigma on 
children when designing a TB screening program.72
Individuals with TB and their health-care providers 
also identify TB stigma as a cause of noncompletion of 
treatment.73–77 Even after the start of therapy, concern 
about being identified as having TB and suffering 
the consequences of TB stigma may lead individuals 
to drop out of treatment programs. TB stigma has 
also been raised as a potential barrier to home- and 
work-based direct observational therapy (DOT), given 
that the presence of TB nurses might mark a person 
as infected.78,79 Collectively, these studies suggest that 
at-risk communities and infected individuals perceive 
that TB stigma causes diagnostic delay and can lead 
to treatment noncompliance.
Attempts to quantify the contribution of TB stigma 
to diagnostic delay and treatment adherence, however, 
have produced mixed results. Kiwuwa and colleagues 
surveyed newly diagnosed TB patients in Uganda to 
assess factors related to the duration of time between 
the onset of symptoms and their first health-care visit. 
Predictors of delays of more than two weeks included 
daily alcohol use and subsistence farming, but not 
perceived TB stigma.80 Similarly, TB stigma was not 
a predictor of significant delay between the onset 
of symptoms and seeking health care in Zambia or 
Syria.81,82 In a study in Cameroon, Cambanis et al. found 
that perceived TB stigma was a significant predictor 
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of delays of more than four weeks, but the associa-
tion disappeared with multivariate adjustment.83 The 
impact of TB stigma on treatment compliance is also 
unclear. Woith and Larson found that, among Russians 
with active pulmonary TB, TB stigma was actually a 
predictor of treatment adherence.84 In contrast, TB 
stigma was the most common motivation cited by 
HIV-infected Tanzanian patients who did not complete 
isoniazid preventive therapy.85 Perceived TB stigma was 
also associated with noncompliance among Pakistani 
patients on DOT.86
Interventions to reduce TB stigma
Relatively few interventions have been introduced to 
reduce TB stigma, and few investigators have measured 
whether reductions in TB stigma decrease diagnostic 
delay or improve treatment compliance. No studies 
have assessed whether decreased TB stigma affects TB 
morbidity or mortality. Several authors have suggested 
that TB education/support programs, aimed at health-
care providers, individuals with TB, and at-risk com-
munity members, may reduce TB stigma, although little 
data exist on the effectiveness of these strategies.87–89 
Rajeswari and colleagues found that perceived TB 
stigma did not change in a surveyed population of TB-
infected individuals in south India after completion of 
a DOT program with an educational component.90
As is true with other stigmatized conditions includ-
ing HIV and mental illness, the most promising 
approach to reducing TB stigma may be to empower 
individuals with TB to resist stigmatizing external judg-
ments, while working to change community norms 
about the disease.2,91,92 For example, several studies 
have assessed the impact of TB clubs, particularly in 
Africa, on perceived TB stigma and treatment compli-
ance.93,94 These clubs, which typically consist of three 
to 10 individuals with TB, are organized by TB health 
workers and meet weekly to offer social support, 
arrange transportation to clinics, encourage treatment 
adherence, and monitor for treatment side effects.93 
They also encourage TB screening among other at-risk 
community members.95 
Using a focus group-based approach, Demissie et al. 
have shown that individuals enrolled in TB clubs per-
ceive themselves to be less affected by TB stigma than 
those receiving standard, clinic-run treatment.94 A likely 
explanation is that TB clubs reduce social isolation and 
offer an environment in which TB status is highly visible 
and accepted. Demissie et al. also found that the pres-
ence of TB clubs in the broader community appears 
to reduce negative attitudes and practices concerning 
TB. In their study, individuals enrolled in Ethiopian TB 
clubs were more likely to complete TB treatment than 
TB-infected patients with similar sociodemographic 
characteristics in areas without TB clubs.
Macq and colleagues conducted a similar study on 
the effect of TB clubs on TB stigma in rural Nicara-
gua.96 Compared with TB patients in municipalities 
without TB clubs, patients enrolled in TB clubs had 
a small but significant reduction in internalized TB 
stigma, as measured on a 10-question stigma assess-
ment scale. There was, however, no difference in 
treatment completion rates between the two popula-
tions. Finally, Liefooghe and colleagues found that 
TB-positive Pakistani patients randomized to receive 
counseling to strengthen their perceived self-efficacy, 
which is often adversely impacted by TB stigma, had a 
13% reduction in treatment defaulting compared with 
patients who did not receive counseling. The interven-
tion was even more beneficial for women, especially 
housewives, among whom the reduction in treatment 
defaulting was 25%.97 
DISCUSSION
Stigmatization is a social determinant of health. Stigma 
occurs because of community and institutional norms 
about undesirable or disvalued behaviors or character-
istics. When diseases are stigmatized, the fear of the 
social and economic consequences following diagnosis 
can make individuals reluctant to seek and complete 
medical care. The structure of a community’s beliefs 
and norms about a disease and the resulting stigma 
can, therefore, substantially impact health. In this 
article, we systematically reviewed the literature on TB 
stigma, including studies that characterized and mea-
sured TB stigma; assessed its impact on TB diagnosis 
and treatment; and explored interventions to reduce 
TB stigma. 
The most common cause of TB stigma is the per-
ceived risk of transmission from TB-infected individuals 
to susceptible community members. Depending on 
geographic region, however, TB is also stigmatized 
because of its associations with HIV, poverty, low social 
class, malnutrition, or disreputable behavior. TB stigma 
has a more significant impact on women and poor or 
less-educated community members, which is especially 
concerning given that these groups are often at higher 
risk for health disparities. TB stigma may, therefore, 
worsen preexisting gender- and class-based health 
disparities. 
Although several survey instruments are in devel-
opment for measuring perceived and internalized TB 
stigma, most research uses qualitative techniques for 
assessing TB stigma. The use of different measure-
ment tools may explain why TB stigma is a predictor 
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of diagnostic delay and treatment nonadherence in 
some studies and not in others. In general, however, 
health-care providers and at-risk community members 
perceive that TB stigma leads to TB diagnostic delay 
and treatment noncompletion. Some interventions, 
particularly TB clubs, have been shown to decrease TB 
stigma and improve TB treatment adherence. However, 
there are no studies that address whether reductions 
in TB stigma correspond with improved TB morbidity 
or mortality. TB clubs may help TB-positive individuals 
resist stigmatization, and they may also change com-
munity norms about TB by increasing the visibility of 
the disease.
Limitations
While several clear themes emerged from our litera-
ture review, it is important to note its limitations. First, 
although stigma is conceptually different from related 
experiences, such as discrimination, bias, and preju-
dice, not all authors make these distinctions in the same 
way. Given our narrowly tailored search strategy, it is 
possible that we may have missed articles relevant to 
TB stigma because they were categorized as involving 
TB discrimination, bias, or prejudice. Second, because 
we focused on the biomedical literature on TB stigma 
as found via PubMed and through review of the refer-
ence sections of identified articles, we may have missed 
articles on TB stigma from sociological or psychological 
resources not indexed in PubMed. 
CONCLUSIONS
Based on our review of the available literature on TB 
stigma, we identified several areas where additional 
research is needed. Figure 2 summarizes these recom-
mendations, which are explained more fully in the 
following sections.
Recommendations for characterizing TB stigma
The origins and consequences of TB stigma have been 
well characterized in multiple geographic regions. 
Because the socioeconomic impact of TB stigma varies 
among different groups (e.g., men and women), it is 
important to continue to investigate the effects of TB 
stigma in other subpopulations including adolescents 
and individuals with latent TB. This information can 
be used to design and target interventions that specifi-
cally address the impact of TB stigma on a given group. 
For example, knowing that women are typically more 
concerned about the effect of TB stigma on their mar-
riages can direct health-care providers to offer specific 
counseling and educational resources about partner 
notification. Because improved TB education has 
been proposed as a method of reducing TB stigma, it 
is important to determine whether knowledge of TB 
transmissibility and transmission routes actually cor-
relates with TB stigma.
Recommendations for measuring TB stigma
The recent introduction and validation of two stigma 
assessment questionnaires is helpful in efforts to mea-
sure and track changes in TB stigma over time.55,56 
These instruments should be tested and validated 
among men and women, in multiple geographic loca-
tions, and in varied ethnic and cultural groups. Wide-
spread adoption of one or more of them, supplemented 
with qualitative data, will allow better comparisons 
among studies. A common stigma assessment tool will 
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also assist in targeting interventions toward particular 
aspects of TB stigma (e.g., self-isolation or hiding one’s 
TB status) as identified using these instruments.
Recommendations for studying the effects  
of TB stigma on TB diagnosis and treatment
An important challenge for future research on TB 
stigma is to better assess the impact of TB stigma on 
TB diagnostic delay and treatment compliance. While 
TB stigma is perceived to have a negative impact on 
prompt TB diagnosis and treatment completion rates, 
studies that formally assessed the effect of TB stigma 
have had mixed findings. The availability of quantita-
tive survey instruments should allow researchers to 
determine whether TB stigma is associated with delay 
between the onset of TB-like symptoms and presenta-
tion to a health-care provider and whether a higher 
degree of TB stigma is associated with longer delay. 
Similar research should examine the impact of TB 
stigma on TB treatment completion rates.
Recommendations for interventions  
to reduce TB stigma
Although community and institutional norms ulti-
mately mediate stigmatization, wide-scale interventions 
to change these norms can be difficult. A more promis-
ing approach appears to be helping TB-infected indi-
viduals resist TB stigma, particularly through TB clubs. 
Additional studies in regions where TB stigma is com-
mon should be conducted to validate the impact of TB 
clubs on TB stigma and to assess whether a reduction 
in TB stigma leads to improved time to TB diagnosis, 
treatment compliance, and, ultimately, reduced TB 
morbidity and mortality. This research should employ 
one of the standardized TB stigma measurement tools 
to track changes in TB stigma over time and to cor-
relate changes in individual- and community-level TB 
stigma with diagnostic delay and treatment completion. 
Assessing TB stigma among individuals at risk for TB 
before and after the introduction of TB clubs can 
also help determine whether the increased visibility 
of TB-infected individuals changes broader norms 
about the disease. Finally, it is essential to continue to 
develop other interventions—for example, counseling 
TB-infected patients or introducing default screening 
policies in high TB prevalence areas—to reduce TB 
stigma. 
It is also important to supplement this bottom-up 
approach to reducing TB stigma with an assessment of 
interventions designed to directly address stigmatizing 
community norms about TB. While greater education 
about the cause and routes of transmission of TB has 
been proposed as a method for reducing TB stigma, 
more research is required to assess whether simply 
providing more information about TB can change 
these norms. Studies from the HIV literature suggest 
that widespread educational efforts have had minimal 
effect on HIV knowledge and only a small effect on 
stigmatization of that disease.98,99 It would, however, be 
useful to assess whether interventions known to reduce 
HIV/AIDS stigma have any effect on TB diagnosis and 
treatment. 
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